GlassScriptPhysician profile
Zubin Batlivala
NPI 1710971957
$18,122.35
in general payments reported to CMS, 2019-2025
11 companies · $516 in 2025
The $516 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $215 · 2020: $45.13 · 2021: $289 · 2022: $251 · 2023: $8,536 · 2024: $8,271 · 2025: $516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Food and Beverage: $1,379 · Education: $25.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,918.17 |
| Food and Beverage | $1,378.69 |
| Education | $25.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $17,433.14 | 2021-2025 | Qulipta, Ubrelvy, Botox |
| Allergan, INC. | $178.32 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $163.04 | 2020-2025 | Belbuca, Xtampza |
| Scilex Pharmaceuticals INC. | $100.14 | 2019 | |
| Novartis Pharmaceuticals Corporation | $77.43 | 2019 | |
| Galderma Laboratories, L.P. | $72.33 | 2024 | |
| Abbott Laboratories | $24.84 | 2023 | Proclaim |
| Lilly USA, LLC | $23.49 | 2019 | |
| Nevro Corp. | $18.67 | 2021 | |
| Valinor Pharma, LLC | $17.07 | 2023 | Movantik |
| Shionogi INC | $13.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zubin Batlivala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.